← SynDRA
RISLENEMDAZ
SynDRA canonical compound SYN0029622 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GRIN2B |
|---|
| Mechanism of action | ionotropic glutamate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- GRIN1 ANTAGONIST
- Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
- GRIN2B ANTAGONIST
- ionotropic glutamate receptor antagonist
Cross-references
Synonyms
- CERC-301
- Rislenemdaz, (-)-
- MK-0657
- MK-0657, (-)-
- 5HAM167S5T
- rislenemdazum
- RefChem:930784
- DTXCID801516862
- Rislenemdaz [USAN]
- MFCD14635204
- 1DY7M91WQ1
- MK-0657, (+/-)-
- Rislenemdaz (USAN)
- C19H23FN4O2
- UNII-1DY7M91WQ1
- UNII-5HAM167S5T
- MK 0657 racemate
- RISLENEMDAZ [INN]
- RISLENEMDAZ [WHO-DD]
- orb1708666
- SCHEMBL4469674
- RISLENEMDAZ, (+/-)-
- RECBFDWSXWAXHY-IAGOWNOFSA-N
- BDBM50385169
- EX-A11132
- AKOS037643749
- CS-7798
- HY-106441A
- AS-35130
- DA-55515
- NS00070336
- D11340
- T12733
Look up RISLENEMDAZ in the interactive SynDRA portal →